Claim Pending

biotech revenues will grow by at least 12% in 2026

Ernst & Young: biotech revenues will grow by at least 12% in 2026 Published Jun 9, 2026. Status: Pending. biotech revenue growth rate in 2026

biotech revenues will grow by at least 12% in 2026

FactTracker assessment

biotech revenue growth rate in 2026

Verification rule: Observed value ≥ 12 %; window 2026-06-09 to 2026-12-31

Verification criteria: biotech revenue growth rate in 2026